publication date: Aug. 3, 2010In this issue: Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand. Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics. In Multi-Site Phase I Studies, No Investigator Sees All Toxicities. Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.